Dr. Frank P. Lin, MD

Dr. Lin practices at Martin Luther King, Jr. Community Hospital in Los Angeles, California, part of County of Los Angeles.

Dr. Lin's NPI, 1821016452, was assigned on July 18, 2006. Dr. Lin graduated from Keck School of Medicine of USC in 1999. Dr. Lin holds California license A78083.

Dr. Lin's primary practice is Martin Luther King, Jr. Community Hospital, at 1680 East 120th Street, Los Angeles, CA 90059 in Los Angeles County. The practice phone is (424) 835-6808.

Dr. Lin's primary practice is Martin Luther King, Jr. Community Hospital in Los Angeles, California, part of County of Los Angeles. Dr. Lin is also affiliated with Los Angeles General Medical Center. The medical group on file is Martin Luther King Jr. Community Medical Group. Dmand AI also links Dr. Lin to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Lin is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Lin is licensed in California.

Dmand AI lists carpal tunnel syndrome, epilepsy, fibromyalgia and chronic pain, head injury, muscle pain, fibromyalgia, and limb pain, parkinson's disease, sleep apnea and vertigo among the conditions Dr. Lin treats.

CMS data shows 229 Medicare services from Dr. Lin across 5 procedure codes in 2024, for 163 Medicare patients. Medicare paid $19,334 for them.

CMS counts 163 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 90% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 59, with 58% women.

In 2024, Dr. Lin wrote 334 Medicare Part D claims for 67 patients. 85% of them were for generic drugs. CMS names the drug for 208 of them, across 11 drugs with 11 or more claims each, at $290,269 in total drug cost. In 2023, CMS named 180 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Lin for performance year 2024, reported through an alternative payment model (APM). Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Lin, published from 2011 to 2016. 2011 was the busiest year, with 2. Dr. Lin's most frequent co-authors are Matthew A. Allison, MD, David McLeod Herrington, MD and Alka M. Kanaya, MD.

CMS Open Payments shows 16 general payments to Dr. Lin from 8 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. UCB, Inc. paid the most, $231.

Dr. Lin graduated from Keck School of Medicine of USC in 1999.

Dr. Lin is in network with 16 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.